1. Home
  2. ADMA vs ITGR Comparison

ADMA vs ITGR Comparison

Compare ADMA & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADMA
  • ITGR
  • Stock Information
  • Founded
  • ADMA 2004
  • ITGR 1970
  • Country
  • ADMA United States
  • ITGR United States
  • Employees
  • ADMA N/A
  • ITGR N/A
  • Industry
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • ITGR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • ADMA Health Care
  • ITGR Health Care
  • Exchange
  • ADMA Nasdaq
  • ITGR Nasdaq
  • Market Cap
  • ADMA 4.1B
  • ITGR 4.4B
  • IPO Year
  • ADMA N/A
  • ITGR 2000
  • Fundamental
  • Price
  • ADMA $16.32
  • ITGR $138.75
  • Analyst Decision
  • ADMA Strong Buy
  • ITGR Strong Buy
  • Analyst Count
  • ADMA 4
  • ITGR 9
  • Target Price
  • ADMA $21.25
  • ITGR $146.50
  • AVG Volume (30 Days)
  • ADMA 2.3M
  • ITGR 162.9K
  • Earning Date
  • ADMA 02-26-2025
  • ITGR 02-13-2025
  • Dividend Yield
  • ADMA N/A
  • ITGR N/A
  • EPS Growth
  • ADMA N/A
  • ITGR 32.56
  • EPS
  • ADMA 0.28
  • ITGR 3.25
  • Revenue
  • ADMA $382,809,000.00
  • ITGR $1,712,620,000.00
  • Revenue This Year
  • ADMA $67.03
  • ITGR $9.73
  • Revenue Next Year
  • ADMA $14.58
  • ITGR $7.31
  • P/E Ratio
  • ADMA $58.22
  • ITGR $42.76
  • Revenue Growth
  • ADMA 63.39
  • ITGR 12.41
  • 52 Week Low
  • ADMA $4.82
  • ITGR $94.56
  • 52 Week High
  • ADMA $23.64
  • ITGR $142.76
  • Technical
  • Relative Strength Index (RSI)
  • ADMA 36.43
  • ITGR 60.65
  • Support Level
  • ADMA $17.82
  • ITGR $129.55
  • Resistance Level
  • ADMA $18.88
  • ITGR $136.14
  • Average True Range (ATR)
  • ADMA 0.84
  • ITGR 2.98
  • MACD
  • ADMA -0.08
  • ITGR 0.33
  • Stochastic Oscillator
  • ADMA 12.01
  • ITGR 98.08

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

About ITGR Integer Holdings Corporation

Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into two business segments based on the product type: medical and nonmedical. The medical segment uses the firm's technologies to produce components and finished medical devices, and it generates the vast majority of revenue. The company earns more than half of its revenue in the United States.

Share on Social Networks: